Young-Joo Ahn

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

D. Sze, D. Kirn, S. Han, 2008, The Lancet. Oncology.

Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial.

Young-Joo Ahn, H. Cheong, Y. Kim, 2010, Vaccine.

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

D. Sze, D. Kirn, S. Han, 2008, The Lancet. Oncology.